Phenylurea Derivatives As Inhibitors Of Tyrosine Kinases For The Treatment Of Tumour Diseases

摘要

Compounds of the formula (I), in which R^1a-R^1e, R^2a, R^2b, R³ and X have the meanings indicated in Claim 1 , are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.